Lund University is celebrating 350 years. Read more on lunduniversity.lu.se

Menu

Javascript is not activated in your browser. This website needs javascript activated to work properly.

CT-proAVP (copeptin), MR-proANP and Peroxiredoxin 4 after cardiac arrest: release profiles and correlation to outcome.

Author:
  • Martin Annborn
  • Josef Dankiewicz
  • Niklas Nielsen
  • Malin Rundgren
  • Gustav Smith
  • S Hertel
  • J Struck
  • Hans Friberg
Publishing year: 2014
Language: English
Pages: 428-436
Publication/Series: Acta Anaesthesiologica Scandinavica
Volume: 58
Issue: 4
Document type: Journal article
Publisher: Wiley-Blackwell

Abstract english

Further characterization of the post-cardiac arrest syndrome (PCAS) is essential to better understand the mechanisms resulting in injury and death. We investigated serial serum concentrations of the stress hormone c-terminal provasopressin (CT-proAVP or copeptin), the cardiac biomarker MR-proANP and a biomarker of oxidation injury, Peroxiredoxin 4 (Prx4) in patients treated with mild hypothermia (MHT) after cardiac arrest, and studied their association to the PCAS and long-term outcome.

Keywords

  • Anesthesiology and Intensive Care

Other

Published
  • ISSN: 0001-5172
E-mail: gustav.smith [at] med.lu.se

Associate professor

Cardiology

+46 46 17 26 33

D1232C

32

Research project participant

Cardiovascular Epigenetics

32

Research project participant

Heart Failure and Mechanical Support

32

Project manager

Molecular Epidemiology and Cardiology

+46 46 17 26 33

32

Lund University Diabetes Centre, CRC, SUS Malmö, Entrance 72, House 91:12. SE-205 02 Malmö. Telephone: +46 40 39 10 00